The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature
Open accessAbstract
PURPOSE: Clinical practice varies widely on the diagnostic role of biopsy for clinically localized renal masses suspicious for renal cell carcinoma. Therefore, we performed a systematic review of the available literature to quantify the accuracy and rate of adverse events of renal mass biopsy. MATERIALS AND METHODS: MEDLINE®, Embase® and the Cochrane databases were searched (January 1997 to May 2015) for relevant studies. The systematic review process established by the Agency for Healthcare Research and Quality was followed. Nondiagnostic biopsies were excluded from diagnostic accuracy calculations. RESULTS: A total of 20 studies with 2,979 patients and 3,113 biopsies were included in the study. The overall nondiagnostic rate was 14.1% with 90.4% of those undergoing surgery found to have malignancy. Repeat biopsy led to diagnosis in 80% of patients. The false-positive rate was low (4.0%), histological and renal cell carcinoma subtype concordance was substantial, and Fuhrman upgrading notable (16%) from low grade (1 to 2) to high grade (3 to 4). Core biopsy was highly sensitive (97.5%, CI 96.5-98.5) and specific (96.2%, CI 90.7-100) when a diagnostic result was obtained, but most patients (∼80%) did not undergo surgery after a benign biopsy. Among patients undergoing extirpation 36.7% with a negative biopsy had malignant disease on surgical pathology (negative predictive value 63.3%, CI 52.4-74.2). Direct complications included hematoma (4.9%), clinically significant pain (1.2%), gross hematuria (1.0%), pneumothorax (0.6%) and hemorrhage (0.4%). CONCLUSIONS: Diagnostic accuracy was generally high for biopsy of localized renal masses with a low complication rate, but the nondiagnostic rate and negative predictive value were concerning. Renal mass sampling should be used judiciously as further research will determine its true clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Renal cell cancer stage migration: Analysis of the National Cancer Data Base
Kane, C. J., Mallin, K., Ritchey, J., Cooperberg, M. R., & Carroll, P. R. (2008) · Cancer · doi:10.1002/cncr.23518 · Cited by 604
NEUZILLET, Y., LECHEVALLIER, E., ANDRE, M., DANIEL, L., & COULANGE, C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000120147.51090.2b · Cited by 308
Global increases in kidney cancer incidence, 1973–1992
Mathew, A., Devesa, S. S., Fraumeni, J. F., & Chow, W.-H. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200204000-00010 · Cited by 306
Diagnostic Accuracy of Computed Tomography-Guided Percutaneous Biopsy of Renal Masses
Schmidbauer, J., Remzi, M., Memarsadeghi, M., Haitel, A., Klingler, H. C., Katzenbeisser, D., Wiener, H., & Marberger, M. (2008) · European Urology · doi:10.1016/j.eururo.2007.11.041 · Cited by 248
Image‐guided biopsy of small renal masses in the era of ablative therapies
Salem, S., Ponsky, L. E., Abouassaly, R., Cherullo, E. E., Isariyawongse, J. P., MacLennan, G. T., Nakamoto, D., & Haaga, J. R. (2012) · International Journal of Urology · doi:10.1111/iju.12010 · Cited by 23
Cited by
Renal Mass and Localized Renal Cancer: AUA Guideline
Campbell, S., Uzzo, R. G., Allaf, M. E., Bass, E. B., Cadeddu, J. A., Chang, A., Clark, P. E., Davis, B. J., Derweesh, I. H., Giambarresi, L., et al. (2017) · Journal of Urology · doi:10.1016/j.juro.2017.04.100 · Cited by 1,242
Self-citationRenal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
Campbell, S. C., Clark, P. E., Chang, S. S., Karam, J. A., Souter, L., & Uzzo, R. G. (2021) · Journal of Urology · doi:10.1097/ju.0000000000001911 · Cited by 775
Renal Cell Carcinoma: A Review
Rose, T. L., & Kim, W. Y. (2024) · JAMA · doi:10.1001/jama.2024.12848 · Cited by 374
Metadata
- Authors
- Patel, H. D., Johnson, M. H., Pierorazio, P. M., Sozio, S. M., Sharma, R., Iyoha, E., Bass, E. B., & Allaf, M. E.
- Venue
- Journal of Urology
- Published
- 2016-05
- Volume
- 195
- Issue
- 5
- Pages
- 1340-1347
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2279958595
- Cited by
- 364
- References
- 7
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature. https://app.cochat.ai/papers/10.1016/j.juro.2015.11.029
- The paper
- Patel, H. D., Johnson, M. H., Pierorazio, P. M., Sozio, S. M., Sharma, R., Iyoha, E., Bass, E. B., & Allaf, M. E. (2016). Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature. Journal of Urology. https://doi.org/10.1016/j.juro.2015.11.029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.